![]() |
Our CompaniesBiomedical Science Consulting Company, BioSciCon, Inc., is a woman-owned, small business start-up biotechnology company focused on R&D of the proprietary MarkPap® technology. BioSciCon has recently organized a consortium of business companies to commercialize the MarkPap® technology as new products emerge from the R&D component after translational research from prototypes to products. The other members of this consortium are MarkPap LLC with mission to commercialize the MarkPap technology and MarkPap Pacific LLC, with limited scope of commercialization of the technology in the emerging economies of China, India and other countries in the wider Pacific region. In the commercial efforts, MarkPap LLC is joined with Information Technologies International, Inc., and SourceIndia, Inc., marketing and business development companies from New Jersey. MarkPap Pacific LLC is joined with Maryland Center in Shanghai, China and Anke Bio, a pharmaceutical and medical device company from Anhui in China. The potential members of the consortium are Ricca Chemical Company, Arlington, TX which is currently manufacturing the MarkPap Kit, Kemp Biotechnologies, Frederick, MD and GT-Vision, Hagerstown, MD. In 2007, BioSciCon sponsored the creation of The Global Academy for Woman's Health, Inc., independent non-profit organization which integrated the multiple prior non-profit activities of BioSciCon's founders continuing their legacy to work for public benefit improving women's health and saving women's lives. Our MissionThe primary mission of BioSciCon, Inc. is to bring the new MarkPap® Technology products to public benefit and save women's lives around the world. The primary function of MarkPap LLC is to commercialize proprietary MarkPap® Technology products after completion of the translational research, and to provide resources for further financing of R&D Who We Are
The President of BioSciCon and MarkPap LLC is Nenad Markovic, M.D., Ph.D. He is an internist, hematologist-oncologist, Professor Emeritus in oncology and author. Dr. Nenad Markovic was a director of clinical departments and the university hospital for hematology oncology, president of professional societies, and a leader of multi-institutional programs. He is an internationally recognized oncologist having published more then 200 scientific publications, including books, chapters and patents. He was organizer, moderator and participant on numerous international congresses and scientific meetings. Dr. Nenad Markovic has also extensive experience in regulatory affairs and safety issues, and has exceptional leadership and people skills. His biography is published in Marquis Who's Who in the World. BioSciCon Cervical Cancer Study Group is a multidisciplinary research group consisting of medical doctors (general practitioners, gynecologists, oncologists and pathologists) from BioSciCon's Clinical and Laboratory Research Sites, and oncologists, biomedical scientists, statisticians, chemists, physicists, computer scientists, and experts in other disciplines affiliated with this program who participate in the BioSciCon's Research Site. Currently active members of the group are highlighted with asterisk. This is a dynamic group of professional teams that are perpetually changing depending on actual programs. Nenad Markovic, MD, PhD* (Research Center), Olivera Markovic, MD, PhD* (Research Center), Lewis Townsend, MD* (Clinical Site), William Smith, MD (Laboratory Site), James Sundeen, MD (Laboratory Site), David Hankins, PhD* (Laboratory Site), Vladan Posarac, MD (Research Center), Mr.Stephen McJonathan* (Microscopy/Imaging), Oleg Panashchenko, PhD* (optical physicist and computer scientist, Research Center), Mr. Derrick Miller (IT/Web), Gary Peck, MD* (Scientific Consultant), Edward Henderson, MD (Scientific Consultant), S. Kati, PhD (statistician, Research Center), Ing. Marjan Cotic* (IT Consultant), Ing. Cvetan Saljinski* (Imaging/Photography Consultant), Shelly Parr, MD (Clinical Site), Jonathan Cosin, MD (Clinical Site), MIlena Simic (Research Center), Allan Ross, MD (Clinical Site), Venkat Iyer, MD (Laboratory Site). Members of this group serve on the Scientific Board per a particular program. Dr. Olivera Markovic coordinates Scientific Board activities. Business Advisory TeamSCORE Counselors to Small Businesses, Chapter 1, Washington, DC provides continuous business support through the Lead Counselor, Ms.Ann Dobbs and other counselors from the Chapter contributing with their particular expertise. BioSciCon is a client of the Frederick Innovation Technology Center, Inc., (FITCI) in Frederick, MD and Mr. Michael Dailey, Executive Director is participating in business development. Mr.Gerard Viegas, President Information Technologies International, Inc. and Dr.Yatin Thakore, PhD, President and CEO SourceIndia, Inc. joined MarkPap LLC as business consultants. Mr. Duc Duong is advisor for China market helping MarkPap Pacific LLC. Shulman, Rogers Law Offices, Rockville, MD provided legal support. Mr.John Naber, Dickinson Wright law firm, Washington, DC is MarkPap LLC patent lawyer. Business professionals constitute The MarkPap LLC Business Development Team, which is coordinated by Dr. Nenad Markovic, President and CEO of MarkPap LLC. AcknowledgementsMarkPap Technology development has been supported in part by SBIR phases 1 and 2 grants from the National Institutes of Health, Bethesda, MD. NIH also provided business development support through the NIH Commercialization Assistance Program (CAP 2006/2007) to foster further commercialization of BioSciCon products. Information about BioSciCon, Inc. and MarkPap® Technology appears on the NIH Web Site, Office of Technology Transfer and SBIR and STTR Success Story for BioSciCon, Inc. |
|